Fabrication and characterization of a 3D bioprinted nanoparticle-hydrogel hybrid device for biomimetic detoxification
Authors:
- 12 September 2017
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 9 (38) , 14506-14511
Abstract
A biomimetic micro/nanodevice is 3D bioprinted using polyethylene glycol (PEG) hydrogel as the supporting platform, along with the red blood cell (RBC) membrane-coated nanoparticles (RBC-NPs) encapsulated in the hydrogel as the detoxification mechanism. RBC-NPs are prepared through a nanoprecipitation and coating method and then mixed into the poly(ethylene glycol) diacrylate (PEGDA) monomer solution for 3D bioprinting through photopolymerization. This resulting detoxification device is engineered with multiple inner channels for the RBC-NPs to nonspecifically soak up the various toxins flowing through the channels. Different shapes (i.e. star or triangle) of the channel are fabricated, each with a larger surface area than the generic circle shape. The device is characterized for microstructure, nanoparticle encapsulation and function, and its detoxification ability. Overall, the strategy of incorporating functional nanoparticles into a biocompatible hydrogel as the supporting platform may enable localized, patient specific controlled therapeutics for detoxification, drug delivery, and other precision medicine application.Keywords
This publication has 22 references indexed in Scilit:
- Engineered biomimetic nanoabsorbent for cellular detoxification of chemotherapeuticsRSC Advances, 2016
- Targeting Staphylococcus aureus Toxins: A Potential form of Anti-Virulence TherapyToxins, 2016
- Engineered nanoparticles mimicking cell membranes for toxin neutralizationAdvanced Drug Delivery Reviews, 2015
- Hydrogel Retaining Toxin‐Absorbing Nanosponges for Local Treatment of Methicillin‐Resistant Staphylococcus aureus InfectionAdvanced Materials, 2015
- 3D bioprinting of tissues and organsNature Biotechnology, 2014
- Anti-virulence strategies to combat bacteria-mediated diseaseNature Reviews Drug Discovery, 2010
- The biology and future prospects of antivirulence therapiesNature Reviews Microbiology, 2008
- Targeting virulence: a new paradigm for antimicrobial therapyNature Chemical Biology, 2007
- Pathogenic Escherichia coliInternational Journal of Medical Microbiology, 2005
- The Global Impact of Drug ResistanceClinical Infectious Diseases, 2003